IBM Watson Health has unveiled a new partnership with the Department of Veterans Affairs to dramatically improve access to cutting-edge cancer care for U.S. veterans. The goal is to help doctors deliver so-called precision medicine to 10,000 American veterans diagnosed with the disease over the next two years.
Veterans suffer disproportionately high cancer diagnosis and mortality rates. As such, the VA delivers treatment to 3.5 percent of U.S. cancer patients — the largest group of cancer patients in the nation.
"I think that is huge," said Steve Harvey, Watson Health vice president. "It is using technology to help those that really need it the most."